Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines

James Stevenson; David S. Ettinger; Douglas E. Wood; Dara L. Aisner; Wallace Akerley; Jessica R. Bauman; Ankit Bharat; Debora S. Bruno; Joe Y. Chang; Lucian R. Chirieac; Malcolm DeCamp; Aakash Desai; Thomas J. Dilling; Jonathan Dowell; Gregory A. Durm; Marina C. Garassino; Scott Gettinger; Travis E. Grotz; Matthew A. Gubens; Rudy P. Lackner; Michael Lanuti; Jules Lin; Billy W. Loo; Christine M. Lovly; Fabien Maldonado; Erminia Massarelli; Daniel Morgensztern; Trey C. Mullikin; Thomas Ng; Gregory A. Otterson; Dawn Owen; Sandip P. Patel; Tejas Patil; Patricio M. Polanco; Gregory J. Riely; Jonathan Riess; Theresa A. Shapiro; Aditi P. Singh; Alda Tam; Tawee Tanvetyanon; Jane Yanagawa; Stephen C. Yang; Edwin Yau; Kristina Gregory; Lisa Hang

doi:10.6004/jnccn.2024.0014

Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines

James Stevenson, David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Marina C. Garassino, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Rudy P. LacknerMichael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Gregory A. Otterson, Dawn Owen, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Theresa A. Shapiro, Aditi P. Singh, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina Gregory, Lisa Hang

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States annually. Pleural mesothelioma is the most common type and represents approximately 85% of these cases. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pleural mesothelioma. These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on disease classification and systemic therapy options.

Original language	English (US)
Pages (from-to)	72-81
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	22
Issue number	2
DOIs	https://doi.org/10.6004/jnccn.2024.0014
State	Published - Mar 2024

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2024.0014

Cite this

Stevenson, J., Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Desai, A., Dilling, T. J., Dowell, J., Durm, G. A., Garassino, M. C., Gettinger, S., Grotz, T. E., Gubens, M. A., ... Hang, L. (2024). Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 22(2), 72-81. https://doi.org/10.6004/jnccn.2024.0014

Stevenson, J, Ettinger, DS, Wood, DE, Aisner, DL, Akerley, W, Bauman, JR, Bharat, A, Bruno, DS, Chang, JY, Chirieac, LR, DeCamp, M, Desai, A, Dilling, TJ, Dowell, J, Durm, GA, Garassino, MC, Gettinger, S, Grotz, TE, Gubens, MA, Lackner, RP, Lanuti, M, Lin, J, Loo, BW, Lovly, CM, Maldonado, F, Massarelli, E, Morgensztern, D, Mullikin, TC, Ng, T, Otterson, GA, Owen, D, Patel, SP, Patil, T, Polanco, PM, Riely, GJ, Riess, J, Shapiro, TA, Singh, AP, Tam, A, Tanvetyanon, T, Yanagawa, J, Yang, SC, Yau, E, Gregory, K & Hang, L 2024, 'Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 22, no. 2, pp. 72-81. https://doi.org/10.6004/jnccn.2024.0014

@article{82eff64b7e4c4dfbb198c63fb2ce26c6,

title = "Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines",

abstract = "Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States annually. Pleural mesothelioma is the most common type and represents approximately 85% of these cases. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pleural mesothelioma. These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on disease classification and systemic therapy options.",

author = "James Stevenson and Ettinger, {David S.} and Wood, {Douglas E.} and Aisner, {Dara L.} and Wallace Akerley and Bauman, {Jessica R.} and Ankit Bharat and Bruno, {Debora S.} and Chang, {Joe Y.} and Chirieac, {Lucian R.} and Malcolm DeCamp and Aakash Desai and Dilling, {Thomas J.} and Jonathan Dowell and Durm, {Gregory A.} and Garassino, {Marina C.} and Scott Gettinger and Grotz, {Travis E.} and Gubens, {Matthew A.} and Lackner, {Rudy P.} and Michael Lanuti and Jules Lin and Loo, {Billy W.} and Lovly, {Christine M.} and Fabien Maldonado and Erminia Massarelli and Daniel Morgensztern and Mullikin, {Trey C.} and Thomas Ng and Otterson, {Gregory A.} and Dawn Owen and Patel, {Sandip P.} and Tejas Patil and Polanco, {Patricio M.} and Riely, {Gregory J.} and Jonathan Riess and Shapiro, {Theresa A.} and Singh, {Aditi P.} and Alda Tam and Tawee Tanvetyanon and Jane Yanagawa and Yang, {Stephen C.} and Edwin Yau and Kristina Gregory and Lisa Hang",

year = "2024",

month = mar,

doi = "10.6004/jnccn.2024.0014",

language = "English (US)",

volume = "22",

pages = "72--81",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "2",

}

TY - JOUR

T1 - Mesothelioma

T2 - Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines

AU - Stevenson, James

AU - Ettinger, David S.

AU - Wood, Douglas E.

AU - Aisner, Dara L.

AU - Akerley, Wallace

AU - Bauman, Jessica R.

AU - Bharat, Ankit

AU - Bruno, Debora S.

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - DeCamp, Malcolm

AU - Desai, Aakash

AU - Dilling, Thomas J.

AU - Dowell, Jonathan

AU - Durm, Gregory A.

AU - Garassino, Marina C.

AU - Gettinger, Scott

AU - Grotz, Travis E.

AU - Gubens, Matthew A.

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Lin, Jules

AU - Loo, Billy W.

AU - Lovly, Christine M.

AU - Maldonado, Fabien

AU - Massarelli, Erminia

AU - Morgensztern, Daniel

AU - Mullikin, Trey C.

AU - Ng, Thomas

AU - Otterson, Gregory A.

AU - Owen, Dawn

AU - Patel, Sandip P.

AU - Patil, Tejas

AU - Polanco, Patricio M.

AU - Riely, Gregory J.

AU - Riess, Jonathan

AU - Shapiro, Theresa A.

AU - Singh, Aditi P.

AU - Tam, Alda

AU - Tanvetyanon, Tawee

AU - Yanagawa, Jane

AU - Yang, Stephen C.

AU - Yau, Edwin

AU - Gregory, Kristina

AU - Hang, Lisa

PY - 2024/3

Y1 - 2024/3

N2 - Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States annually. Pleural mesothelioma is the most common type and represents approximately 85% of these cases. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pleural mesothelioma. These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on disease classification and systemic therapy options.

AB - Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States annually. Pleural mesothelioma is the most common type and represents approximately 85% of these cases. The NCCN Guidelines for Mesothelioma: Pleural provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pleural mesothelioma. These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on disease classification and systemic therapy options.

UR - http://www.scopus.com/inward/record.url?scp=85188761187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85188761187&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0014

DO - 10.6004/jnccn.2024.0014

M3 - Article

C2 - 38503043

AN - SCOPUS:85188761187

SN - 1540-1405

VL - 22

SP - 72

EP - 81

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 2

ER -

Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this